Bayer to license Cedilla’s selective inhibitors in precision oncology

By NS Healthcare Staff Writer

02 Jun 23

The license agreement provides Bayer with exclusive rights to develop and commercialise Cedilla’s CyclinE1/CDK2 inhibitors that are currently…

PharmaceuticalsPartnerships and Licensing Agreements

InDex Pharmaceuticals, Viatris sign deal to commercialise cobitolimod in Japan

By NS Healthcare Staff Writer

01 Jun 23

Cobitolimod, a TLR9 agonist, is currently undergoing evaluation in the global phase III programme, known as CONCLUDE, as…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Astellas, Sony announce research collaboration for ADC platform in oncology

By NS Healthcare Staff Writer

17 May 23

Astellas and Sony will jointly develop and optimise a new ADC platform using KIRAVIA Backbone as a linker,…

PharmaceuticalsPartnerships and Licensing Agreements

Gilead, Arcus expand research partnership to include inflammatory diseases

By NS Healthcare Staff Writer

16 May 23

Arcus will receive an upfront payment of $35m and will commence research programs against up to four targets,…

PharmaceuticalsPartnerships and Licensing Agreements

SERB obtains US rights to SFJ’s ticagrelor reversal agent bentracimab

By NS Healthcare Staff Writer

12 May 23

Bentracimab is a novel, monoclonal antibody fragment that reverses the antiplatelet activity of ticagrelor, an antiplatelet medicine marketed…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Nanobiotix in talks to develop and commercialise cancer drug NBTXR3

By NS Healthcare Staff Writer

08 May 23

The biotechnology company has entered negotiations with a major global pharmaceutical company, for the development and commercialisation of…

PharmaceuticalsPartnerships and Licensing Agreements

Moderna teams up with Novocol for fill-finish, packaging of mRNA vaccines in Canada

By NS Healthcare Staff Writer

05 May 23

Under the terms of the agreement, Novocol Pharma will provide fill-finish and packaging for vaccines manufactured at Moderna’s…

PharmaceuticalsContract Manufacturing

Volastra in-licenses Amgen’s sovilnesib; secures $60m funding

By NS Healthcare Staff Writer

08 Mar 23

The financing, led by founding investors Polaris Partners and ARCH Venture Partners alongside Lilly, will support Volastra’s portfolio…

PharmaceuticalsPartnerships and Licensing Agreements

FDB agrees to manufacture Argenx’s antibody therapy efgartigimod

By NS Healthcare Staff Writer

28 Oct 22

Under the agreement, FDB will provide drug substance manufacturing of efgartigimod at its large-scale biomanufacturing facility in Hillerød,…

PharmaceuticalsContract Manufacturing

AstraZeneca, Gatehouse Bio extend partnership to develop RNA therapeutics for heart failure

By NS Healthcare Staff Writer

09 Sep 22

The collaboration will combine AstraZeneca’s expertise in RNA therapeutics with Gatehouse Bio’s capabilities in small RNA compounds to…

PharmaceuticalsPartnerships and Licensing Agreements